These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 14629655)

  • 1. Pilot study of the safety and effect of intranasal delipidated acid-treated Mycobacterium vaccae in adult asthma.
    Shirtcliffe PM; Goldkorn A; Weatherall M; Tan PL; Beasley R
    Respirology; 2003 Dec; 8(4):497-503. PubMed ID: 14629655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of delipidated deglycolipidated (DDMV) and heat-killed Mycobacterium vaccae in asthma.
    Shirtcliffe PM; Easthope SE; Cheng S; Weatherall M; Tan PL; Le Gros G; Beasley R
    Am J Respir Crit Care Med; 2001 May; 163(6):1410-4. PubMed ID: 11371410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of repeated intradermal injections of heat-inactivated Mycobacterium bovis bacillus Calmette-Guérin in adult asthma.
    Shirtcliffe PM; Easthope SE; Weatherall M; Beasley R
    Clin Exp Allergy; 2004 Feb; 34(2):207-12. PubMed ID: 14987299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised placebo controlled trial of delipidated, deglycolipidated Mycobacterium vaccae as immunotherapy for psoriatic arthritis.
    Dalbeth N; Yeoman S; Dockerty JL; Highton J; Robinson E; Tan PL; Herman D; McQueen FM
    Ann Rheum Dis; 2004 Jun; 63(6):718-22. PubMed ID: 15140780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in psoriasis after intradermal administration of delipidated, deglycolipidated Mycobacterium vaccae (PVAC): results of an open-label trial.
    Balagon MV; Tan PL; Prestidge R; Cellona RV; Abalos RM; Tan EV; Walsh GP; Watson JD; Walsh DS
    Clin Exp Dermatol; 2001 May; 26(3):233-41. PubMed ID: 11422164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium vaccae administration during allergen sensitization or challenge suppresses asthmatic features.
    Smit JJ; Van Loveren H; Hoekstra MO; Schijf MA; Folkerts G; Nijkamp FP
    Clin Exp Allergy; 2003 Aug; 33(8):1083-9. PubMed ID: 12911782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, blinded, parallel group, placebo controlled pilot study evaluating the effect of PVAC treatment in patients with diffuse systemic sclerosis.
    Genovese MC; Chakravarty EF; Boyle DL; Tutuncu Z; Thorburn CM; Halilhodzic M; Kroll S; Baughman J; Stewart S; Kavanaugh A
    J Rheumatol; 2005 Dec; 32(12):2345-50. PubMed ID: 16331761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Mycobacterium vaccae immunization on lung histopathology in a murine model of chronic asthma.
    Ozdemir C; Akkoc T; Bahceciler NN; Kucukercan D; Barlan IB; Basaran MM
    Clin Exp Allergy; 2003 Feb; 33(2):266-70. PubMed ID: 12580921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterium vaccae Nebulization Can Protect against Asthma in Balb/c Mice by Regulating Th9 Expression.
    Li C; Jiang X; Luo M; Feng G; Sun Q; Chen Y
    PLoS One; 2016; 11(8):e0161164. PubMed ID: 27518187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Mycobacterium vaccae on atopic dermatitis in children of different ages.
    Arkwright PD; David TJ
    Br J Dermatol; 2003 Nov; 149(5):1029-34. PubMed ID: 14632810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of vaccae on airway inflammation and Th1/Th2 cytokines in sensitized mice].
    Xie Q; Bian R; Wu K; Zheng X
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Aug; 25(8):488-92. PubMed ID: 12425837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II randomized, placebo-controlled trial of M. vaccae-derived protein (PVAC) for the treatment of psoriasis.
    Netto EM; Takahashi D; de Fátima Paim de Oliveira M; Barbosa P; Ferraz N; Paixão A; Oyafuso LK; Bortoletto C; Matos D; Paixão M; da Silva AO; Badaro R
    Vaccine; 2006 Jun; 24(23):5056-63. PubMed ID: 16621200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Airway hyperresponsiveness, late allergic response, and eosinophilia are reversed with mycobacterial antigens in ovalbumin-presensitized mice.
    Hopfenspirger MT; Agrawal DK
    J Immunol; 2002 Mar; 168(5):2516-22. PubMed ID: 11859146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open study to assess the efficacy clinically and immunologically of M. vaccae vaccine in patients with atopic dermatitis.
    Davies MG; Symons C; Shaw S; Kaminski ER
    J Dermatolog Treat; 2006; 17(2):74-7. PubMed ID: 16766329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a Mycobacterium vaccae derivative on paediatric atopic dermatitis: a randomized, controlled trial.
    Brothers S; Asher MI; Jaksic M; Stewart AW
    Clin Exp Dermatol; 2009 Oct; 34(7):770-5. PubMed ID: 19438539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic treatment with heat-killed Mycobacterium vaccae (SRL172) in a mild and severe mouse model for allergic asthma.
    Smit JJ; Van Loveren H; Hoekstra MO; Van der Kant PA; Folkerts G; Nijkamp FP
    Eur J Pharmacol; 2003 Jun; 470(3):193-9. PubMed ID: 12798958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pre-immunization by killed Mycobacterium bovis and vaccae on immunoglobulin E response in ovalbumin-sensitized newborn mice.
    Tükenmez F; Bahçeciler NN; Barlan IB; Başaran MM
    Pediatr Allergy Immunol; 1999 May; 10(2):107-11. PubMed ID: 10478612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in psoriasis after intradermal administration of heat-killed Mycobacterium vaccae.
    Balagon MV; Walsh DS; Tan PL; Cellona RV; Abalos RM; Tan EV; Fajardo TT; Watson JD; Walsh GP
    Int J Dermatol; 2000 Jan; 39(1):51-8. PubMed ID: 10651968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intradermal injection of heat-killed Mycobacterium vaccae in dogs with atopic dermatitis: a multicentre pilot study.
    Ricklin Gutzwiller ME; Reist M; Peel JE; Seewald W; Brunet LR; Roosje PJ
    Vet Dermatol; 2007 Apr; 18(2):87-93. PubMed ID: 17355422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease.
    Arkwright PD; David TJ
    J Allergy Clin Immunol; 2001 Mar; 107(3):531-4. PubMed ID: 11240956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.